Table 1 Patient characteristics
PDS | DLS | NACT | P | |
|---|---|---|---|---|
n = 85 | n = 38 | n = 58 | ||
Age, mean (range) | 55.8 (29–79) | 50.8 (27–69) | 59.7 (38–79) | <0.001 |
>75 | 5 (5.9%) | 0 (0.0%) | 5 (8.6%) | |
ASA score | ||||
1 | 16 (18.8%) | 13 (34.2%) | 6 (10.3%) | <0.001 |
2 | 44 (51.8%) | 22 (57.9%) | 26 (44.8%) | |
3 | 24 (28.2%) | 0 (0.0%) | 26 (44.8%) | |
BMI [IQR] | 23.8 [20.9; 25.2] | 24.1 [21.1; 25.4] | 22.5 [20.6; 24.1] | 0.236 |
CA125, U/mL (range) | 1829.4 (44–22,743) | 2191.7 (75–13,637) | 3828.7 (102–17,094) | 0.005 |
Stage | ||||
IIIC | 51 (60%) | 31 (81.6%) | 11 (19.0%) | <0.001 |
IV | 34 (40%) | 7 (18.4%) | 47 (81.0%) | |
Grade | ||||
1 | 5 (5.9%) | 2 (5.3%) | 3 (5.2%) | 0.708 |
2 | 28 (32.9%) | 8 (21.1%) | 11 (19.0%) | |
3 | 45 (52.9%) | 26 (68.4%) | 39 (67.2%) | |